Recent data also supported the role of FNDC5/irisin in alleviating oxidative stress caused by doxorubicin-induced cardiac toxicity in an AKT/mTOR-dependent pathway, with improved the sensitivity of the tumor response to chemotherapy (Liu et al., 2019; Zhang et al., 2019). The gene discussed is MTOR; the disease is neoplasm.